For the last six to seven weeks, Gland Pharma stock has witnessed a series of consolidations as prices fluctuated in the range of 1700-1850 levels. It broke out from the said range last week. Traders ...

The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

The first lock-in period for anchor investors, freeing 50% of stocks held by them, is expiring for 14 newly listed stocks ...

Will Retail Investors Make Money Through IPOs in 2025? Insights from Sugandha Sachdeva. The year 2024 was a landmark for ...

Since its listing on December 18, Vishal Mega Mart, which operates supermarket chains across 30 states and Union Territories ...

Vishal Mega Mart's peer companies like Avenue Supermarts and V2 Retail reported strong business updates for the December ...

The initial public offering (IPO) market in the Asia-Pacific (APAC) region has demonstrated resilience in 2024, with a ...

With multiple growth levers in place, this established retail chain can continue its success in 2025. However, valuations may play spoilsport.